HOUGEN ELIZABETH L 4
4 · Artiva Biotherapeutics, Inc. · Filed Jun 26, 2025
Insider Transaction Report
Form 4
HOUGEN ELIZABETH L
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2025-06-24+13,750→ 13,750 totalExercise: $1.61Exp: 2035-06-23→ Common Stock (13,750 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in full on the earlier of June 24, 2026, or the date of the Issuer's 2026 annual stockholder meeting.